Balance between macrophage migration inhibitory factor and sCD74 predicts outcome in patients with acute decompensation of cirrhosis.
JHEP Rep
; 3(2): 100221, 2021 Apr.
Article
em En
| MEDLINE
| ID: mdl-33659891
ACLF, acute-on-chronic liver failure; ALT, alanine aminotransferase; AST, aspartate aminotransferase; Acute-on-chronic liver failure; Biomarker; CRP, C-reactive protein; CXCL10, C-X-C motif chemokine; HCC, hepatocellular carcinoma; Inflammation; Liver cirrhosis; MELD, model for end-stage liver disease; MIF, macrophage migration inhibitory factor; SBP, spontaneous bacterial peritonitis; SDC, stable decompensated cirrhosis; SHR, subdistribution hazard ratio; SNP, single nucleotide polymorphism; Survival; TIPS, transjugular intrahepatic portosystemic shunt; UDC, unstable decompensated cirrhosis; WBC, white blood cell count; sCD74, soluble receptor CD74
Texto completo:
1
Base de dados:
MEDLINE
Tipo de estudo:
Prognostic_studies
/
Risk_factors_studies
Idioma:
En
Ano de publicação:
2021
Tipo de documento:
Article